Financhill
Sell
8

GOCO Quote, Financials, Valuation and Earnings

Last price:
$5.75
Seasonality move :
-24.85%
Day range:
$5.57 - $5.83
52-week range:
$5.57 - $21.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.08x
P/B ratio:
0.26x
Volume:
46.8K
Avg. volume:
57.3K
1-year change:
-41.33%
Market cap:
$63.9M
Revenue:
$798.9M
EPS (TTM):
-$1.20

Analysts' Opinion

  • Consensus Rating
    GoHealth has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 1 Hold rating, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $25.60, GoHealth has an estimated upside of 345.22% from its current price of $5.75.
  • Price Target Downside
    According to analysts, the lowest downside price target is $18.00 representing 100% downside risk from its current price of $5.75.

Fair Value

  • According to the consensus of 5 analysts, GoHealth has 345.22% upside to fair value with a price target of $25.60 per share.

GOCO vs. S&P 500

  • Over the past 5 trading days, GoHealth has underperformed the S&P 500 by -17.19% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • GoHealth does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • GoHealth has grown year-over-year revenues for 2 quarters straight. In the most recent quarter GoHealth reported revenues of $221M.

Earnings Growth

  • GoHealth has grown year-over-year earnings for 0 quarters straight. In the most recent quarter GoHealth reported earnings per share of -$0.52.
Enterprise value:
737M
EV / Invested capital:
0.79x
Price / LTM sales:
0.08x
EV / EBIT:
9.38x
EV / Revenue:
0.88x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-12.55x
Price / Operating cash flow:
9.63x
Enterprise value / EBITDA:
3.99x
Gross Profit (TTM):
$702.4M
Return On Assets:
0.14%
Net Income Margin (TTM):
0.23%
Return On Equity:
0.44%
Return On Invested Capital:
0.21%
Operating Margin:
3.34%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue $544.2M $737.1M $834.3M $185.6M $221M
Gross Profit $379M $585.6M $702.4M $147.6M $181.7M
Operating Income -$263.7M -$67.3M $4.4M -$4M $7.4M
EBITDA -$191.6M $26.3M $184.7M $22.8M $33.7M
Diluted EPS -$16.81 -$7.07 -$1.20 -$1.04 -$0.52
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets $320.8M $391.8M $375.5M $397.1M $260.9M
Total Assets $2.1B $2B $1.5B $1.4B $1.4B
Current Liabilities $99.6M $140.9M $209.8M $300M $233.4M
Total Liabilities $701.4M $1.1B $970.9M $959.4M $931.1M
Total Equity $1.4B $860M $572.6M $435.8M $451M
Total Debt $400.2M $667.9M $509.5M $485.3M $485.9M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Cash Flow Statement
Cash Flow Operations $26.9M $101.2M -$46.5M $12.5M -$12.4M
Cash From Investing -$9.7M -$16.1M $5.3M -$4.6M -$3M
Cash From Financing -$114.3M -$19.7M -$34.3M -$942K -$3.2M
Free Cash Flow $17.2M $85.1M -$58.7M $8M -$15.5M
GOCO
Sector
Market Cap
$63.9M
$613.4M
Price % of 52-Week High
27.38%
86.42%
Dividend Yield
0%
2.06%
Shareholder Yield
2.9%
4.07%
1-Year Price Total Return
-41.33%
7.82%
Beta (5-Year)
--
0.587
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $6.54
200-day SMA
Sell
Level $11.63
Bollinger Bands (100)
Sell
Level 9.51 - 16.37
Chaikin Money Flow
Sell
Level -7.9M
20-day SMA
Sell
Level $7.91
Relative Strength Index (RSI14)
Sell
Level 22.46
ADX Line
Sell
Level 43.1
Williams %R
Buy
Level -94.3396
50-day SMA
Sell
Level $10.17
MACD (12, 26)
Sell
Level -1.28
25-day Aroon Oscillator
Sell
Level -96
On Balance Volume
Sell
Level -7.2M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.4504)
Sell
CA Score (Annual)
Level (-1.4628)
Buy
Beneish M-Score (Annual)
Level (-2.4599)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (12.2235)
Buy
Piotroski F Score (Annual)
Level (4)
Buy
Quality Ratio Score
Level (6)
Sell
Fundamental Score
Level (4)

Revenue Forecast

Earnings per Share Forecast

Company Profile

GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers’ peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer’s specific needs.

Stock Forecast FAQ

In the current month, GOCO has received 4 Buy ratings 1 Hold ratings, and 0 Sell ratings. The GOCO average analyst price target in the past 3 months is $25.60.

  • Where Will GoHealth Stock Be In 1 Year?

    According to analysts, the consensus estimate is that GoHealth share price will rise to $25.60 per share over the next 12 months.

  • What Do Analysts Say About GoHealth?

    Analysts are divided on their view about GoHealth share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that GoHealth is a Sell and believe this share price will drop from its current level to $18.00.

  • What Is GoHealth's Price Target?

    The price target for GoHealth over the next 1-year time period is forecast to be $25.60 according to 5 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.

  • Is GOCO A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for GoHealth is a Buy. 4 of 5 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of GOCO?

    You can purchase shares of GoHealth via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase GoHealth shares.

  • What Is The GoHealth Share Price Today?

    GoHealth was last trading at $5.75 per share. This represents the most recent stock quote for GoHealth. Yesterday, GoHealth closed at $5.75 per share.

  • How To Buy GoHealth Stock Online?

    In order to purchase GoHealth stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will DigitalOcean Stock Bounce Back?
Will DigitalOcean Stock Bounce Back?

DigitalOcean (NYSE:DOCN) has run into the proverbial brick wall with…

Where Will Cognizant Stock Be In 5 Years?
Where Will Cognizant Stock Be In 5 Years?

Cognizant Technologies (NASDAQ:CTSH) is a global provider of IT services…

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

NVIDIA (NASDAQ:NVDA) and Broadcom (NASDAQ:AVGO) are two of the hottest…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 45x

Sell
33
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Buy
60
MRUS alert for May 24

Merus NV [MRUS] is up 32.55% over the past day.

Buy
57
RGC alert for May 24

Regencell Bioscience Holdings [RGC] is up 28.43% over the past day.

Buy
90
OKLO alert for May 24

Oklo [OKLO] is up 23.11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock